Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Long-term effects of radiopharmaceuticals

20.08.2010
Low-level radioactive substances are used in medicine for diagnosing cancer, among other things. Progress in this area is the objective of a European project coordinated at the university hospital in Würzburg.

Are there cancer cells in the thyroid? Have metastases detached themselves from a tumor and moved elsewhere in the body?

Diagnostic questions such as these can be answered by nuclear physicians using low-level, short-lived radioactive substances. These so-called radiopharmaceuticals spread throughout the organism in a unique fashion and accumulate in large numbers in cancer cells, for example. Their radioactive signal can be measured, thereby revealing the location of tumor cells.

Now in Europe for the first time the basic scientific principles for all permitted radiopharmaceuticals will be systematically presented and assessed – as part of the PEDDOSE.NET project. The European Commission is providing EUR 500,000 in funding.

Goals of the project

One of the goals is to describe current knowledge relating to any effects of low-level radioactive pharmaceuticals on health. The focus is on substances administered to children and young people for diagnostic purposes. Within the project, the scientists will collate and assess data on anticipated exposure to radiation and any associated risks. They then aim to recommend how these data should be collated in the development of new radiopharmaceuticals.

A further goal for PEDDOSE.NET is to devise recommendations and guidelines in order to drive scientific and technological innovations. For example, the scientists believe that it will be possible in future to administer radiopharmaceuticals in even smaller doses, thereby further reducing the hypothetical risk to patients.

Another of the project’s goals is to identify any areas in which further clinical studies may be required. On every issue the scientists will collaborate with the authorities responsible for approving new substances.

Results expected in fall 2011

It is expected that the project will be completed in fall 2011. Its results should further improve radiation protection for patients and make the use of nuclear-medical examinations even more targeted than it is now.

Partners involved in the project

Five partner institutes from four European countries are involved in PEDDOSE.NET; the scientific coordinator is Professor Michael Laßmann, chief physicist at the Department of Nuclear Medicine of the University of Würzburg.

The project is being coordinated by the European Institute for Biomedical Imaging Research (EIBIR) in Vienna. It has the support of the European Association of Nuclear Medicine (EANM). The project consortium is made up of members of the EANM Dosimetry Committee and experts from the German Federal Office for Radiation Protection.

Homepage of the PEDDOSE.NET project: http://www.peddose.net

Contact

Prof. Dr. Michael Laßmann, Department of Nuclear Medicine, University of Würzburg, T +49 (0)931 201-35500, lassmann@nuklearmedizin.uni-wuerzburg.de

Robert Emmerich | idw
Further information:
http://www.peddose.net
http://www.uni-wuerzburg.de

More articles from Health and Medicine:

nachricht Researchers release the brakes on the immune system
18.10.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Osaka university researchers make the slipperiest surfaces adhesive

18.10.2017 | Materials Sciences

Space radiation won't stop NASA's human exploration

18.10.2017 | Physics and Astronomy

Los Alamos researchers and supercomputers help interpret the latest LIGO findings

18.10.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>